MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Hologic Company Profile (NASDAQ:HOLX)

Consensus Ratings for Hologic (NASDAQ:HOLX) (?)
Ratings Breakdown: 1 Sell Rating(s), 8 Hold Rating(s), 8 Buy Rating(s)
Consensus Rating:Hold (Score: 2.41)
Consensus Price Target: $36.27 (4.63% downside)

Current Analysts' Coverage Summary for Hologic (NASDAQ:HOLX)
Show:
DateFirmActionRatingPrice TargetActions
7/30/2015BTIG ResearchReiterated RatingNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/30/2015Canaccord GenuityReiterated RatingBuy$45.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/30/2015BarclaysBoost Price TargetUnderweight$31.00 -> $40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/24/2015Bank of AmericaInitiated CoverageBuy$43.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/14/2015Piper JaffrayDowngradeOverweight -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/13/2015Evercore Partners Inc.Reiterated RatingBuy -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/13/2015Evercore ISIDowngradeBuy -> Hold$37.50 -> $38.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/1/2015Cowen and CompanyBoost Price TargetMarket Perform$35.00 -> $40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/4/2015ArgusBoost Price TargetBuy$38.00 -> $43.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/30/2015Jefferies GroupBoost Price TargetBuy$34.00 -> $38.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/25/2015RBC CapitalBoost Price TargetSector Perform$31.00 -> $32.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/5/2015Needham & Company LLCDowngradeBuy -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/29/2015JPMorgan Chase & Co.Boost Price TargetOverweight$31.00 -> $32.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/20/2015William BlairUpgradeMarket Perform -> OutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/30/2014Goldman SachsUpgradeBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/27/2014Craig HallumUpgradeHold -> BuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/5/2014Barrington ResearchDowngradeOutperform -> Market PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/31/2014SunTrustReiterated RatingR$15.00 -> $18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/2/2014Standpoint ResearchDowngradeBuy -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/4/2014Cantor FitzgeraldReiterated RatingBuy$21.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/6/2014Morgan StanleyDowngradeOverweight -> Equal Weight$22.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/12/2013Citigroup Inc.Reiterated RatingNeutral$24.00 -> $22.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/30/2013Ned Davis ResearchDowngradeNeutral -> SellView Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/11/2013Raymond JamesDowngradeOutperform -> Market Perform$23.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/30/2013 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha